BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19026950)

  • 1. Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of (188)Re-DXR-liposome in C26 colon carcinoma ascites mice model.
    Chen LC; Chang CH; Yu CY; Chang YJ; Wu YH; Lee WC; Yeh CH; Lee TW; Ting G
    Nucl Med Biol; 2008 Nov; 35(8):883-93. PubMed ID: 19026950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model.
    Chang YJ; Chang CH; Yu CY; Chang TJ; Chen LC; Chen MH; Lee TW; Ting G
    Nucl Med Biol; 2010 Jan; 37(1):95-104. PubMed ID: 20122674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy.
    Chang CH; Stabin MG; Chang YJ; Chen LC; Chen MH; Chang TJ; Lee TW; Ting G
    Cancer Biother Radiopharm; 2008 Dec; 23(6):749-58. PubMed ID: 19111045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution, pharmacokinetics and imaging of (188)Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model.
    Chen LC; Chang CH; Yu CY; Chang YJ; Hsu WC; Ho CL; Yeh CH; Luo TY; Lee TW; Ting G
    Nucl Med Biol; 2007 May; 34(4):415-23. PubMed ID: 17499731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing mice.
    Chen MH; Chang CH; Chang YJ; Chen LC; Yu CY; Wu YH; Lee WC; Yeh CH; Lin FH; Lee TW; Yang CS; Ting G
    Anticancer Res; 2010 Jan; 30(1):65-72. PubMed ID: 20150618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model.
    Chen LC; Wu YH; Liu IH; Ho CL; Lee WC; Chang CH; Lan KL; Ting G; Lee TW; Shien JH
    Nucl Med Biol; 2012 Jan; 39(1):35-43. PubMed ID: 21958858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PEGylated liposomal doxorubicin improves the delivery and therapeutic efficiency of 188Re-Liposome by modulating phagocytosis in C26 murine colon carcinoma tumor model.
    Hsu WH; Liu SY; Chang YJ; Chang CH; Ting G; Lee TW
    Nucl Med Biol; 2014 Oct; 41(9):765-71. PubMed ID: 25027866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model.
    Lin LT; Chang CH; Yu HL; Liu RS; Wang HE; Chiu SJ; Chen FD; Lee TW; Lee YJ
    J Nucl Med; 2014 Nov; 55(11):1864-70. PubMed ID: 25349220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.
    Tsai CC; Chang CH; Chen LC; Chang YJ; Lan KL; Wu YH; Hsu CW; Liu IH; Ho CL; Lee WC; Ni HC; Chang TJ; Ting G; Lee TW
    Int J Nanomedicine; 2011; 6():2607-19. PubMed ID: 22114492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging and therapeutic efficacy of 188Re-(DXR)-liposome-BBN in AR42J pancreatic tumor-bearing mice.
    Chang YJ; Yu CY; Hsu CW; Lee WC; Chen SJ; Chang CH; Lee TW
    Oncol Rep; 2012 Nov; 28(5):1736-42. PubMed ID: 22922965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-bMEDA-liposome in a C26 murine colon carcinoma solid tumor animal model.
    Chang YJ; Chang CH; Chang TJ; Yu CY; Chen LC; Jan ML; Luo TY; Lee TW; Ting G
    Anticancer Res; 2007; 27(4B):2217-25. PubMed ID: 17695506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.
    Hsu CW; Chang YJ; Chang CH; Chen LC; Lan KL; Ting G; Lee TW
    Cancer Biother Radiopharm; 2012 Oct; 27(8):481-9. PubMed ID: 23067100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model.
    Soundararajan A; Bao A; Phillips WT; Perez R; Goins BA
    Nucl Med Biol; 2009 Jul; 36(5):515-24. PubMed ID: 19520292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative plasma and tissue distribution of Sun Pharma's generic doxorubicin HCl liposome injection versus Caelyx
    Burade V; Bhowmick S; Maiti K; Zalawadia R; Jain D; Rajamannar T
    Cancer Chemother Pharmacol; 2017 May; 79(5):899-913. PubMed ID: 28349166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models.
    Lin YY; Chang CH; Li JJ; Stabin MG; Chang YJ; Chen LC; Lin MH; Tseng YL; Lin WJ; Lee TW; Ting G; Chang CA; Chen FD; Wang HE
    Cancer Biother Radiopharm; 2011 Jun; 26(3):373-80. PubMed ID: 21711113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
    Burade V; Bhowmick S; Maiti K; Zalawadia R; Ruan H; Thennati R
    BMC Cancer; 2017 Jun; 17(1):405. PubMed ID: 28587612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model.
    Lin YY; Li JJ; Chang CH; Lu YC; Hwang JJ; Tseng YL; Lin WJ; Ting G; Wang HE
    Cancer Biother Radiopharm; 2009 Aug; 24(4):453-60. PubMed ID: 19694580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy.
    Goins B; Bao A; Phillips WT
    Methods Mol Biol; 2010; 606():469-91. PubMed ID: 20013416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
    Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
    Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats.
    Yokoe J; Sakuragi S; Yamamoto K; Teragaki T; Ogawara K; Higaki K; Katayama N; Kai T; Sato M; Kimura T
    Int J Pharm; 2008 Apr; 353(1-2):28-34. PubMed ID: 18082345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.